Search

everythinglearnresearchcommunity

for

Search:↓

People with no symptoms or mild COVID-19 have lower antibody levels, increasing their risk of getting COVID-19 again.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

Long COVID patients may have hormonal imbalances linked to their symptoms.

The IGRA test effectively detects past SARS-CoV-2 exposure, especially using nucleocapsid peptides.

Vaccination reduces COVID-19 severity, and some symptoms like hair loss can persist for a year.

Healthcare workers with a positive COVID-19 test were more likely to report long-COVID symptoms.

Healthcare workers with COVID-19 reported more long-term symptoms, and physical activity may help reduce some of these symptoms.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Organoids can help study COVID-19 and develop treatments, but face challenges like instability and limited renewal.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

COVID-19 temporarily affects male reproductive health, but sperm and testosterone levels generally return to normal after three months.

Human placenta hydrolysate may help treat COVID-19 by reducing virus replication and boosting immune response.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

SARS-CoV-2 proteins help the virus avoid the immune system, delaying response and increasing inflammation.

COVID-19 may worsen Parkinson's disease by affecting certain brain proteins.

Infectious virus was not found after the third remdesivir dose, suggesting early end of isolation is possible.

Long COVID is a big health problem needing more research and better treatments.

Continued vaccine and drug development is crucial due to new virus variants and regional infection spikes.

Genetic differences affect how people respond to COVID-19.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

More symptoms during initial COVID infection increase the risk of long-term effects.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Vaccines work well in Netherton syndrome patients, similar to healthy people.

Balancing testosterone may reduce COVID-19 severity.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.